Cargando…

Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia

Detalles Bibliográficos
Autores principales: Roeker, Lindsey E., Knorr, David A., Pessin, Melissa S., Ramanathan, Lakshmi V., Thompson, Meghan C., Leslie, Lori A., Zelenetz, Andrew D., Mato, Anthony R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450257/
https://www.ncbi.nlm.nih.gov/pubmed/32855439
http://dx.doi.org/10.1038/s41375-020-01030-2
_version_ 1783574779594276864
author Roeker, Lindsey E.
Knorr, David A.
Pessin, Melissa S.
Ramanathan, Lakshmi V.
Thompson, Meghan C.
Leslie, Lori A.
Zelenetz, Andrew D.
Mato, Anthony R.
author_facet Roeker, Lindsey E.
Knorr, David A.
Pessin, Melissa S.
Ramanathan, Lakshmi V.
Thompson, Meghan C.
Leslie, Lori A.
Zelenetz, Andrew D.
Mato, Anthony R.
author_sort Roeker, Lindsey E.
collection PubMed
description
format Online
Article
Text
id pubmed-7450257
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-74502572020-08-27 Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia Roeker, Lindsey E. Knorr, David A. Pessin, Melissa S. Ramanathan, Lakshmi V. Thompson, Meghan C. Leslie, Lori A. Zelenetz, Andrew D. Mato, Anthony R. Leukemia Letter Nature Publishing Group UK 2020-08-27 2020 /pmc/articles/PMC7450257/ /pubmed/32855439 http://dx.doi.org/10.1038/s41375-020-01030-2 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Letter
Roeker, Lindsey E.
Knorr, David A.
Pessin, Melissa S.
Ramanathan, Lakshmi V.
Thompson, Meghan C.
Leslie, Lori A.
Zelenetz, Andrew D.
Mato, Anthony R.
Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia
title Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia
title_full Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia
title_fullStr Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia
title_full_unstemmed Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia
title_short Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia
title_sort anti-sars-cov-2 antibody response in patients with chronic lymphocytic leukemia
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450257/
https://www.ncbi.nlm.nih.gov/pubmed/32855439
http://dx.doi.org/10.1038/s41375-020-01030-2
work_keys_str_mv AT roekerlindseye antisarscov2antibodyresponseinpatientswithchroniclymphocyticleukemia
AT knorrdavida antisarscov2antibodyresponseinpatientswithchroniclymphocyticleukemia
AT pessinmelissas antisarscov2antibodyresponseinpatientswithchroniclymphocyticleukemia
AT ramanathanlakshmiv antisarscov2antibodyresponseinpatientswithchroniclymphocyticleukemia
AT thompsonmeghanc antisarscov2antibodyresponseinpatientswithchroniclymphocyticleukemia
AT leslieloria antisarscov2antibodyresponseinpatientswithchroniclymphocyticleukemia
AT zelenetzandrewd antisarscov2antibodyresponseinpatientswithchroniclymphocyticleukemia
AT matoanthonyr antisarscov2antibodyresponseinpatientswithchroniclymphocyticleukemia